Načítá se...
IT-31 HARNESSING THE IMMUNOLOGIC CAPACITY OF THE LIVER AGAINST GLIOBLASTOMA MULTIFORME
BACKGROUND: Glioblastoma multiforme (GBM) remains invariably associated with poor patient outcomes thus necessitating the development of more targeted therapeutics. To circumvent the challenges associated with cellular therapeutics, we have utilized clinical-grade nanoparticle (NP) vaccine formulati...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218248/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou258.29 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|